Tag Archives: Galapagos NV

November, 2018

October, 2018

September, 2018

June, 2018

July, 2017

  • 28 July

    Servier Licenses GLPG1972 in Osteoarthritis from Galapagos

    28 July 2017 – As a result of their research collaboration, Servier announces today that it has exercised its option to develop novel osteoarthritis molecule GLPG1972/S201086 from Galapagos NV (Euronext/NASDAQ: GLPG), thus obtaining global commercial rights outside the U.S. Osteoarthritis (OA) is a highly prevalent and disabling pathology, considered as …